Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The PUMP Trial: HAI + Systemic Therapy for Unresectable Colorectal Liver Metastases
NCT05863195Phase 3Recruiting
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Apr 2024
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of floxuridine in colorectal cancer (CRC) (2 arms), sponsored by ECOG-ACRIN Cancer Research Group. Primary endpoint: Overall Survival up to 5 years. Started Apr 2024; status: recruiting.
02
Drugs
floxuridine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05863195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863195.